|
End-of-day quote
Buenos Aires S.E.
2026-09-01
|
5-day change | 1st Jan Change | ||
| 23,210.00 ARS | +1.49% |
|
-2.03% | +39.23% |
| 09-01 | UK regulator suspends rare-disease drug Tavneos for new patients over unreliable data | RE |
| 09-01 | Vertex Names Jonathan Poole Finance Chief as Crinetics Buy Closes | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 232B | |||||
| 1,031B | |||||
| 641B | - | - | - | ||
| 453B | |||||
| 349B | |||||
| 290B |
- Stock Market
- Stocks
- AMGN Stock
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
